Abivax initiated at Buy by Goldman Sachs
Goldman Sachs initiated Abivax with a Buy rating and set a $155.00 per-share price target.ed Ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.